Mathieu Kerneis Selected Research

Mathieu Kerneis Research Topics

Disease

27	Myocardial Infarction 10/2023 - 11/2012
21	Thrombosis (Thrombus) 12/2023 - 11/2012
21	Hemorrhage 10/2023 - 01/2013
19	ST Elevation Myocardial Infarction 10/2023 - 08/2015
13	Stroke (Strokes) 11/2022 - 11/2012
11	Acute Coronary Syndrome 11/2021 - 01/2013
8	Atrial Fibrillation 11/2022 - 01/2018
7	Myocarditis (Carditis) 10/2023 - 01/2019
6	Venous Thromboembolism 11/2018 - 01/2018
5	Cardiogenic Shock 01/2022 - 08/2015
5	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022 - 12/2017
4	Heart Failure 01/2023 - 09/2018
4	Pulmonary Embolism 01/2022 - 01/2018
3	COVID-19 12/2022 - 05/2021
3	Coronary Artery Disease (Coronary Atherosclerosis) 11/2019 - 09/2014
3	Acute Kidney Injury (Acute Renal Failure) 03/2019 - 01/2018
2	Takotsubo Cardiomyopathy 01/2022 - 01/2022
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2019
2	Diabetes Mellitus 04/2019 - 01/2019
2	Chronic Renal Insufficiency 01/2019 - 01/2018
2	Heart Arrest (Cardiac Arrest) 01/2018 - 10/2015
2	Renal Insufficiency (Renal Failure) 01/2018 - 11/2015
1	Pulmonary Hypertension 01/2023
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2023
1	Myotoxicity 01/2023
1	Autoimmune Diseases (Autoimmune Disease) 12/2022
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 12/2022
1	Liver Diseases (Liver Disease) 11/2022
1	Asthma (Bronchial Asthma) 11/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2022
1	Shock 01/2022
1	Embolism (Embolus) 01/2022
1	COVID-19 related adult multisystem inflammatory disease 01/2022
1	Neoplasms (Cancer) 11/2021

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2018
8	Enoxaparin (Lovenox)FDA LinkGeneric 04/2019 - 10/2015
7	betrixabanIBA 04/2019 - 12/2017
6	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 10/2023 - 06/2017
6	AnticoagulantsIBA 10/2023 - 10/2015
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 09/2014
6	TicagrelorIBA 04/2019 - 10/2015
6	Prasugrel Hydrochloride FDA Link 06/2017 - 01/2013
5	CreatinineIBA 11/2022 - 08/2015
5	RivaroxabanIBA 11/2019 - 01/2018
4	omega-Chloroacetophenone (Mace)IBA 11/2021 - 01/2020
4	Warfarin (Coumadin)FDA LinkGeneric 11/2019 - 01/2018
4	Vitamin K FDA Link 11/2019 - 01/2018
4	Heparin (Liquaemin)FDA LinkGeneric 12/2018 - 10/2015
4	fibrin fragment D (D-dimer)IBA 11/2018 - 12/2017
4	Clopidogrel (Plavix)FDA Link 06/2017 - 02/2013
3	apixabanIBA 10/2023 - 11/2019
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2023 - 01/2021
3	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2019
3	CholesterolIBA 11/2019 - 12/2018
3	vasodilator-stimulated phosphoproteinIBA 11/2015 - 01/2013
2	TroponinIBA 10/2023 - 12/2022
2	Abatacept (Orencia)FDA Link 01/2023 - 01/2019
2	Troponin IIBA 01/2022 - 01/2019
2	InterleukinsIBA 01/2022 - 10/2020
2	Complement System Proteins (Complement)IBA 01/2022 - 01/2022
2	HDL CholesterolIBA 11/2019 - 12/2018
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 10/2023
1	edoxabanIBA 10/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Janus Kinase InhibitorsIBA 01/2023
1	ruxolitinibIBA 01/2023
1	Antiphospholipid AntibodiesIBA 12/2022
1	VaccinesIBA 10/2022
1	Antipsychotic Agents (Antipsychotics)IBA 10/2022
1	Antineoplastic Agents (Antineoplastics)IBA 10/2022
1	SalicylatesIBA 10/2022
1	LipidsIBA 09/2022
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Etomidate FDA LinkGeneric 01/2022
1	anti-RNA-polymerase III autoantibodyIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022
1	pro-brain natriuretic peptide (1-76)IBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	Arginine Vasopressin (Argipressin)IBA 01/2022
1	Interleukin-8 (Interleukin 8)IBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 11/2021
1	B7-H1 AntigenIBA 11/2021
1	COVID-19 VaccinesIBA 06/2021
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021
1	alirocumabIBA 01/2021
1	evolocumabIBA 01/2021

Therapy/Procedure

30	Percutaneous Coronary Intervention 11/2021 - 01/2013
16	Therapeutics 10/2023 - 06/2017
15	Stents 03/2020 - 11/2012
2	Bioprosthesis 12/2023 - 01/2022
2	Transcatheter Aortic Valve Replacement 12/2023 - 10/2023
2	Extracorporeal Membrane Oxygenation 01/2022 - 01/2018
1	Heart Transplantation (Grafting, Heart) 01/2023
1	Artificial Respiration (Mechanical Ventilation) 01/2023
1	Immunotherapy 10/2022
1	Secondary Prevention 09/2022
1	Treatment Delay 05/2021